{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:55:36Z","timestamp":1781679336446,"version":"3.54.5"},"reference-count":41,"publisher":"Norwegian Medical Association","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"published-print":{"date-parts":[[2017,2,16]]},"DOI":"10.4045\/tidsskr.16.0210","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T08:36:41Z","timestamp":1487752601000},"page":"284-7","source":"Crossref","is-referenced-by-count":2,"title":["Multippel sklerose \u2013 en mitokondriemediert sykdom?"],"prefix":"10.4045","volume":"137","author":[{"given":"Kristin N.","family":"Varhaug","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian A.","family":"Vedeler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalampos","family":"Tzoulis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence A.","family":"Bindoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","reference":[{"key":"3589957_ref_1","unstructured":"McKay KA, Jahanfar S, Duggan T et al. Factors associated with onset, relapses or progression in multiple sclerosis: A systematic review. Neurotoxicology 2016. E-publisert 1.4.2016."},{"key":"3589957_ref_2","first-page":"1175\u2009\u2013\u200989","volume":"132","author":"Frischer JM, Bramow S, Dal-Bianco A et al","year":"Brain","journal-title":"2"},{"key":"3589957_ref_3","doi-asserted-by":"crossref","unstructured":"Trapp BD, Peterson J, Ransohoff RM et al. Axonal transection in the lesions of multiple sclerosis. N\u00a0Engl J Med 1998; 338: 278\u2009\u2013\u200985.","DOI":"10.1056\/NEJM199801293380502"},{"key":"3589957_ref_4","first-page":"411\u2009\u2013\u20098","volume":"10","author":"Witte ME, Geurts JJG, de Vries HE et al","year":"Mitochondrion","journal-title":"4"},{"key":"3589957_ref_5","doi-asserted-by":"crossref","unstructured":"Gorman GS, Chinnery PF, DiMauro S et al. Mitochondrial diseases. Nat Rev Dis Primers 2016; 2: 16080.","DOI":"10.1038\/nrdp.2016.80"},{"key":"3589957_ref_6","unstructured":"Lax NZ, Gorman GS, Turnbull DM. Invited Review: Central nervous system involvement in mitochondrial disease. Neuropathol Appl Neurobiol 2016. -Epublisert 11.6.2016."},{"key":"3589957_ref_7","first-page":"266\u2009\u2013\u200977","volume":"22","author":"Franco-Iborra S, Vila M, Perier C","year":"Neuroscientist","journal-title":"7"},{"key":"3589957_ref_8","doi-asserted-by":"crossref","unstructured":"Stys PK, Zamponi GW, van Minnen J et al. Will the real multiple sclerosis please stand up? Nat Rev Neurosci 2012; 13: 507\u2009\u2013\u200914.","DOI":"10.1038\/nrn3275"},{"key":"3589957_ref_9","doi-asserted-by":"crossref","unstructured":"Gilgun-Sherki Y, Melamed E, Offen D. The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J Neurol 2004; 251: 261\u2009\u2013\u20098.","DOI":"10.1007\/s00415-004-0348-9"},{"key":"3589957_ref_10","doi-asserted-by":"crossref","unstructured":"Sas K, Robotka H, Toldi J et al. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. J Neurol Sci 2007; 257: 221\u2009\u2013\u200939.","DOI":"10.1016\/j.jns.2007.01.033"},{"key":"3589957_ref_11","doi-asserted-by":"crossref","unstructured":"West AP, Shadel GS, Ghosh S. Mitochondria in innate immune responses. Nat Rev Immunol 2011; 11: 389\u2009\u2013\u2009402.","DOI":"10.1038\/nri2975"},{"key":"3589957_ref_12","doi-asserted-by":"crossref","unstructured":"Lassmann H, van Horssen J. The molecular basis of neurodegeneration in multiple sclerosis. FEBS Lett 2011; 585: 3715\u2009\u2013\u200923.","DOI":"10.1016\/j.febslet.2011.08.004"},{"key":"3589957_ref_13","first-page":"1914\u2009\u2013\u200924","volume":"134","author":"Haider L, Fischer MT, Frischer JM et al","year":"Brain","journal-title":"13"},{"key":"3589957_ref_14","doi-asserted-by":"crossref","unstructured":"van Horssen J, Schreibelt G, Drexhage J et al. Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression. Free Radic Biol Med 2008; 45: 1729\u2009\u2013\u200937.","DOI":"10.1016\/j.freeradbiomed.2008.09.023"},{"key":"3589957_ref_15","first-page":"1722\u2009\u2013\u200935","volume":"131","author":"Mahad D, Ziabreva I, Lassmann H et al","year":"Brain","journal-title":"15"},{"key":"3589957_ref_16","doi-asserted-by":"crossref","unstructured":"Carvalho KS. Mitochondrial dysfunction in demyelinating diseases. Semin Pediatr Neurol 2013; 20: 194\u2009\u2013\u2009201.","DOI":"10.1016\/j.spen.2013.09.001"},{"key":"3589957_ref_17","first-page":"1161\u2009\u2013\u200974","volume":"132","author":"Mahad DJ, Ziabreva I, Campbell G et al","year":"Brain","journal-title":"17"},{"key":"3589957_ref_18","first-page":"1827\u2009\u2013\u200937","volume":"58","author":"Ziabreva I, Campbell G, Rist J et al","year":"Glia","journal-title":"18"},{"key":"3589957_ref_19","doi-asserted-by":"crossref","unstructured":"Mahad DH, Trapp BD, Lassmann H. Pathological mechanisms in progressive multiple sclerosis. Lancet Neurol 2015; 14: 183\u2009\u2013\u200993.","DOI":"10.1016\/S1474-4422(14)70256-X"},{"key":"3589957_ref_20","doi-asserted-by":"crossref","unstructured":"Birsa N, Norkett R, Higgs N et al. Mitochondrial trafficking in neurons and the role of the Miro family of GTPase proteins. Biochem Soc Trans 2013; 41: 1525\u2009\u2013\u200931.","DOI":"10.1042\/BST20130234"},{"key":"3589957_ref_21","first-page":"1062\u2009\u2013\u20095","volume":"337","author":"Youle RJ, van der Bliek AM","year":"Science","journal-title":"21"},{"key":"3589957_ref_22","doi-asserted-by":"crossref","unstructured":"Kiryu-Seo S, Ohno N, Kidd GJ et al. Demyelination increases axonal stationary mitochondrial size and the speed of axonal mitochondrial transport. J\u00a0Neurosci 2010; 30: 6658\u2009\u2013\u200966.","DOI":"10.1523\/JNEUROSCI.5265-09.2010"},{"key":"3589957_ref_23","doi-asserted-by":"crossref","unstructured":"Craner MJ, Newcombe J, Black JA et al. Molecular changes in neurons in multiple sclerosis: altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na+\/Ca2+ exchanger. Proc Natl Acad Sci U S A 2004; 101: 8168\u2009\u2013\u200973.","DOI":"10.1073\/pnas.0402765101"},{"key":"3589957_ref_24","doi-asserted-by":"crossref","unstructured":"Trapp BD, Stys PK. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol 2009; 8: 280\u2009\u2013\u200991.","DOI":"10.1016\/S1474-4422(09)70043-2"},{"key":"3589957_ref_25","doi-asserted-by":"crossref","unstructured":"Forte M, Gold BG, Marracci G et al. Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. Proc Natl Acad Sci U S A 2007; 104: 7558\u2009\u2013\u200963.","DOI":"10.1073\/pnas.0702228104"},{"key":"3589957_ref_26","doi-asserted-by":"crossref","unstructured":"Su KG, Banker G, Bourdette D et al. Axonal degeneration in multiple sclerosis: the mitochondrial hypothesis. Curr Neurol Neurosci Rep 2009; 9: 411\u2009\u2013\u20097.","DOI":"10.1007\/s11910-009-0060-3"},{"key":"3589957_ref_27","doi-asserted-by":"crossref","unstructured":"Witte ME, B\u00f8 L, Rodenburg RJ et al. Enhanced number and activity of mitochondria in multiple sclerosis lesions. J Pathol 2009; 219: 193\u2009\u2013\u2009204.","DOI":"10.1002\/path.2582"},{"key":"3589957_ref_28","doi-asserted-by":"crossref","unstructured":"van Horssen J, Witte ME, Ciccarelli O. The role of mitochondria in axonal degeneration and tissue repair in MS. Mult Scler 2012; 18: 1058\u2009\u2013\u200967.","DOI":"10.1177\/1352458512452924"},{"key":"3589957_ref_29","doi-asserted-by":"crossref","unstructured":"Dutta R, McDonough J, Yin X et al. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 2006; 59: 478\u2009\u2013\u200989.","DOI":"10.1002\/ana.20736"},{"key":"3589957_ref_30","doi-asserted-by":"crossref","unstructured":"Errea O, Moreno B, Gonzalez-Franquesa A et al. The disruption of mitochondrial axonal transport is an early event in neuroinflammation. J Neuroinflammation 2015; 12: 152.","DOI":"10.1186\/s12974-015-0375-8"},{"key":"3589957_ref_31","doi-asserted-by":"crossref","unstructured":"Hares K, Kemp K, Rice C et al. Reduced axonal motor protein expression in non-lesional grey matter in multiple sclerosis. Mult Scler 2014; 20: 812\u2009\u2013\u200921.","DOI":"10.1177\/1352458513508836"},{"key":"3589957_ref_32","doi-asserted-by":"crossref","unstructured":"Hares K, Redondo J, Kemp K et al. Axonal motor protein KIF5A and associated cargo deficits in multiple sclerosis lesional and normal-appearing white matter. Neuropathol Appl Neurobiol 2016; n\/a; Epub ahead of print.","DOI":"10.1111\/nan.12305"},{"key":"3589957_ref_33","doi-asserted-by":"crossref","unstructured":"Lu F, Selak M, O'Connor J et al. Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J Neurol Sci 2000; 177: 95\u2009\u2013\u2009103.","DOI":"10.1016\/S0022-510X(00)00343-9"},{"key":"3589957_ref_34","doi-asserted-by":"crossref","unstructured":"Campbell GR, Worrall JT, Mahad DJ. The central role of mitochondria in axonal degeneration in multiple sclerosis. Mult Scler 2014; 20: 1806\u2009\u2013\u200913.","DOI":"10.1177\/1352458514544537"},{"key":"3589957_ref_35","doi-asserted-by":"crossref","unstructured":"Campbell GR, Ziabreva I, Reeve AK et al. Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. Ann Neurol 2011; 69: 481\u2009\u2013\u200992.","DOI":"10.1002\/ana.22109"},{"key":"3589957_ref_36","doi-asserted-by":"crossref","unstructured":"Sparaco M, Schon EA, DiMauro S et al. Myoclonic epilepsy with ragged-red fibers (MERRF): an immunohistochemical study of the brain. Brain Pathol 1995; 5: 125\u2009\u2013\u200933.","DOI":"10.1111\/j.1750-3639.1995.tb00586.x"},{"key":"3589957_ref_37","doi-asserted-by":"crossref","unstructured":"Witte ME, Mahad DJ, Lassmann H et al. Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis. Trends Mol Med 2014; 20: 179\u2009\u2013\u200987.","DOI":"10.1016\/j.molmed.2013.11.007"},{"key":"3589957_ref_38","doi-asserted-by":"crossref","unstructured":"Krysko DV, Agostinis P, Krysko O et al. Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol 2011; 32: 157\u2009\u2013\u200964.","DOI":"10.1016\/j.it.2011.01.005"},{"key":"3589957_ref_39","first-page":"104\u2009\u2013\u20097","volume":"464","author":"Zhang Q, Raoof M, Chen Y et al","year":"Nature","journal-title":"39"},{"key":"3589957_ref_40","doi-asserted-by":"crossref","unstructured":"Yousefi S, Gold JA, Andina N et al. Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med 2008; 14: 949\u2009\u2013\u200953.","DOI":"10.1038\/nm.1855"},{"key":"3589957_ref_41","first-page":"481\u2009\u2013\u200992","volume":"13","author":"Malik AN, Czajka A","year":"Mitochondrion","journal-title":"41"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:21:15Z","timestamp":1781677275000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2017\/02\/oversiktsartikkel\/multippel-sklerose-en-mitokondriemediert-sykdom"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,16]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,2,21]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.16.0210","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,16]]}}}